Internal Medicine, Hematology & Oncology · Calhoun, GA
NPI
1255751277
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1035 Red Bud Rd NE Ste 101
Calhoun, GA, 30701
Phone (706) 625-4285
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
843 services
Medicare patients, 2024
421
Average age 73
Drug cost, 2024
$5.9M
2,207 prescriptions
Company payments, 2025
$837
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mayur D Mody was code 99214 (office e&m - established), 504 times for 282 patients. In total Mayur D Mody billed 843 services in 12 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 504 | 282 | $67.42 | $34K |
| 99215 Office E&M - Established | Facility | 84 | 56 | $106.36 | $8,934 |
| 99213 Office E&M - Established | Facility | 80 | 76 | $43.15 | $3,452 |
| 99205 Office E&M - New | Facility | 60 | 60 | $128.73 | $7,724 |
| 99223 Hospital E&M - Initial | Facility | 40 | 35 | $130.37 | $5,215 |
| 99204 Office E&M - New | Facility | 31 | 31 | $101.27 | $3,139 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 12 | $89.92 | $1,619 |
By year: 2022 $76K for 1,243 services; 2023 $55K for 773 services; 2024 $65K for 843 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mayur D Mody prescribed most often to Medicare patients was Anastrozole, with 202 prescriptions and refills. In total Mayur D Mody wrote 2,207 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 202 | 394 | 59 | $2,814 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 113 | 113 | 42 | $2,679 |
| Eliquis Apixaban | 113 | 125 | 27 | $75K |
| Oxycodone Hcl Generic | 101 | 101 | 23 | $1,905 |
| Gabapentin Generic | 69 | 87 | 15 | $1,003 |
| Morphine Sulfate Er Morphine Sulfate | 64 | 65 | 13 | $1,757 |
| Ondansetron Hcl Generic | 59 | 59 | 22 | $287 |
| Xtandi Enzalutamide | 55 | 55 | Under 11 | $780K |
| Exemestane Generic | 51 | 71 | Under 11 | $3,470 |
| Prednisone Generic | 50 | 50 | 28 | $186 |
| Letrozole Generic | 42 | 80 | Under 11 | $423 |
| Ibrance Palbociclib | 41 | 41 | Under 11 | $653K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 37 | 37 | 14 | $1,053 |
| Ondansetron Odt Ondansetron | 34 | 34 | 13 | $296 |
| Alprazolam Generic | 33 | 33 | Under 11 | $154 |
Brand drugs: - claims; generic drugs: 1,721 claims; opioid claims: 388.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mayur D Mody $837 ($837 in general payments such as food, travel and fees) from 21 companies. The largest payer was Pfizer Inc. with $155.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 8 | $155 |
| Array Biopharma Inc PFE | 8 | $73.24 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $72.45 |
| Merck Sharp & Dohme LLC MRK | 2 | $64.37 |
| Genzyme Corporation SNY | 3 | $60.13 |
| Daiichi Sankyo Inc. 4568.T | 2 | $40.36 |
| Exelixis Inc. EXEL | 2 | $38.5 |
| Eisai Inc. 4523.T | 2 | $34.5 |
| Astellas Pharma US Inc 4503.T | 1 | $32.96 |
| Coherus Oncology, Inc. CHRS | 1 | $29.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.